We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamuel Heath Regulatory News (HSM)

Share Price Information for Samuel Heath (HSM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 275.00
Bid: 250.00
Ask: 300.00
Change: 0.00 (0.00%)
Spread: 50.00 (20.00%)
Open: 275.00
High: 275.00
Low: 275.00
Prev. Close: 275.00
HSM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

18 Nov 2022 07:00

RNS Number : 8236G
Heath(Samuel) & Sons PLC
18 November 2022
 

SAMUEL HEATH & SONS plc

("the Company")

 

UNAUDITED INTERIM REPORT

 

Half year ended 30 September 2022

 

CHAIR'S STATEMENT

 

As predicted in the year end statement, our trading performance for the six months to 30 September 2022 reflected continuing resilience in the sales line but a tightening of margins compared to the outperformance of last year.

Sales increased 9.5% to £7.56m (2021: £6.9m) but this was largely due to currency movements rather than volume growth. The strength of the dollar compared to sterling has had a materially beneficial effect as a significant proportion of our foreign sales is denominated in dollars.

Profit before tax was £521k compared to £776k in the six months to 30 September 2021. As expected, costs have increased disproportionately since last year for a number of reasons. A proactive decision was taken to restore selling and marketing costs to pre-pandemic levels, particularly by resuming attendance at international trade fairs (which were mostly cancelled during lockdowns), but also in augmenting our sales teams at home and abroad. Another area where costs were increased is product development where more frequent new product launches are targeted.

As might be expected, we have been adversely affected by the general rise in energy and other costs, with our combined electricity and gas cost more than doubling. Avoiding supply chain disruption has also been a key concern and we have had to increase order lead times and build stock levels, so as to minimise delays in production. In addition, the recruitment market is very tight particularly for the skills required on the factory floor; this is a key concern in light of inevitable retirements in our loyal but aging workforce. Credit is therefore due to our operations team for the fact that, despite these problems, customer order lead times have held up well, with, we believe, a number of our competitors suffering much worse on this key measure.

First half performance was commendable in the current economic environment and the executive team are to be congratulated for managing the challenges so well. The order book has held up well to date, but talk of a worldwide recession is likely to affect customer sentiment. Strains on the supply chain and labour market are of increasing concern and energy costs will increase further. We are therefore hesitant to predict a result for the second half of the year.

Our balance sheet remains robust with net assets increasing to £11.1m (2021: £6.1m) and cash and cash equivalents of £3.5m (2021: £4.9m which included the £950k cash received from the Business Interruption Loan (since repaid) referenced in note 6). The significant increase in net assets was due to the reduction of the pension liability from £6.2m to zero, calculated under IAS 19 rules, resulting from higher interest rates and gilt yields (see note 7). Shareholders should note however that the next formal actuarial valuation is not due until 31 March 2025.

 

 

 

 

 

Anthony Buttanshaw

Chair

17 November 2022

 

 

Dividend

The directors recommend the maintenance of the interim dividend at 5.5p per share (2021: 5.5p). The interim dividend will be paid on 24 March 2023 to shareholders on the register at the close of business on 24 February 2023. The ex-dividend date for this payment is 23 February 2023.

For further information, please contact:

Samuel Heath & Sons Plc

Simon Latham, Company Secretary 0121 766 4200

 

Cairn Financial Advisers LLP

James Caithie / Jo Turner 020 7213 0880

 

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

 

Unaudited Interim Financial Report

For the Half Year ended 30 September 2022

 

CONSOLIDATED INCOME STATEMENT

Half year

Half year

Year

ended 30

ended 30

ended 31

September

September

March

2022

2021

2022

Unaudited

Unaudited

Audited

£'000

£'000

£'000

 

 

 

Revenue

7,560

6,904

14,015

 

Cost of sales

(3,938)

(3,510)

(6,975)

 

Gross profit

3,622

3,394

7,040

 

Selling and distribution costs

(1,981)

(1,510)

(2,917)

Administrative expenses

(1,031)

(1,051)

(1,986)

Other operating income - grants (note 5)

-

15

15

 

Operating profit

610

848

2,152

 

Finance income

-

 10

10

Finance cost

(89)

(82)

(132)

 

Profit/(loss) before taxation

521

776

2,030

 

Taxation

(33)

(125)

(558)

 

 

 

Profit for the period

 

488

 

651

 

1,472

 

 

 

 

Basic and diluted earnings per ordinary share (note 4)

19.3p

25.7p

58.1p

 

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

 

Half year ended 30 September

Half year ended 30 September

Year ended 31 March

 

2022

2021

2022

Unaudited

Unaudited

Audited

£'000

£'000

£'000

 

 

 

 

Profit for the period

488

 

651

1,472

 

 

 

 

 

 

 

 

Items that will not be reclassified to profit or loss:

 

 

Actuarial profit/(loss) on defined benefit pension scheme

4,210

 

 (316)

693

Deferred tax on actuarial loss

(1,052)

 

60

(173)

Deferred tax rate change

 

 

298

381

 

 

3,158

 

42

901

 

 

Total comprehensive income for the period

3,646

 

693

2,373

 

 

 

 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

 

At 30 September

 

 At 30 September

 

At 31 March

 

 

2022

 

2021

 

2022

 

 

Unaudited

 

Unaudited

 

Audited

 

£'000

 

£'000

 

£'000

Non-current assets

 

 

 

 

 

Intangible assets

505

 

191

442

Property, plant and equipment

3,891

 

3,345

3,670

Deferred tax assets

-

 

997

425

 

 

 

4,396

 

4,533

4,537

 

 

 

Current assets

 

 

Inventories

4,188

 

3,718

3,916

Trade and other receivables

2,115

 

2,113

1,836

Cash and cash equivalents

3,479

 

4,909

4,410

 

9,782

 

10,740

10,162

 

 

Total assets

14,178

 

15,273

14,699

 

 

 

Current liabilities

 

 

Trade and other payables

(2,017)

 

(1,862)

(1,982)

Right of use lease liabilities

(60)

 

(26)

(62)

Borrowings (note 6)

-

 

(84)

-

Current tax payable

(79)

 

(101)

(13)

(2,156)

 

(2,073)

(2,057)

 

 

Non-current liabilities

 

 

Right of use liabilities

(87)

 

-

(129)

Borrowings (note 6)

-

 

(866)

-

Deferred tax liability

(806)

 

-

-

Retirement benefit scheme (note 7)

-

 

(6,198)

(4,837)

 

(893)

 

(7,064)

(4,966)

 

 

Total liabilities

(3,049)

 

(9,137)

(7,023)

Net assets

11,129

 

6,136

7,676

 

 

Equity

 

 

Called up share capital

254

 

254

254

Capital redemption reserve

109

 

109

109

Revaluation reserve

Retained earnings

1,145

9,621

 

1,125

4,548

1,186

6,127

 

 

Equity shareholders' funds

11,129

 

6,136

7,676

 

 

 

 

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

Attributable to owners of the Parent Company

 

 

Share capital

Capital redemption reserve

Revaluation reserve

Retained earnings

Total equity

 

£000

£000

£000

£000

£000

 

 

 

 

 

 

Balance at 31 March 2021

254

109

1,267

3,987

5,617

 

Total transactions with owners

Equity dividends paid

-

-

-

(174)

 (174)

Loss for the period

-

-

-

651

651

Other comprehensive income for the period

Reclassification of depreciation on revaluation

 

-

 

-

-

 

-

-

 

(42)

42

 

42

42

 

-

Total comprehensive income for the period

-

-

(42)

735

693

 

 

 

 

 

 

Balance at 30 September 2021

254

109

1,225

4,548

6,136

 

Total transactions with owners

Equity dividends paid

-

-

-

(140)

(140)

Profit for the period

-

-

-

821

821

Other comprehensive income for the period

Reclassification of depreciation on revaluation

 

-

 

-

-

 

-

-

 

(39)

859

 

39

859

 

-

Total comprehensive income for the period

-

-

(39)

1,719

1,680

 

 

 

 

 

 

Balance at 31 March 2022

254

109

1,186

6,127

7,676

Total transactions with owners

Equity dividends paid

-

-

-

(193)

(193)

Profit for the period

-

-

-

488

488

Other comprehensive income for the period

Reclassification of depreciation on revaluation

 

-

 

-

-

 

-

-

 

(41)

3,158

 

41

3,158

 

-

Total comprehensive income for the period

-

-

(41)

3,687

3,646

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 30 September 2022

254

109

1,145

9,621

11,129

 

 

 

 

 

 

CONSOLIDATED CASH FLOW STATEMENT

 

Half year ended 30 September

Half year ended 30 September

Year ended 31 March

2022

2021

2022

Unaudited

Unaudited

Audited

£'000

£'000

£'000

Cash flow from operating activities

 

 

 

 

Profit for the period before taxation

521

776

2030

 

Adjustments for:

 

Depreciation

168

150

359

Amortisation

48

24

50

Loss/(profit) on disposal of property, plant and equipment

(1)

10

4

Net finance costs/(income)

-

(10)

(12)

Defined benefit pension scheme expenses

83

106

170

Contributions to defined benefit pension scheme

(533)

(518)

(1,036)

 

Operating cash flow before movements in working capital

286

538

1,565

 

 

Changes in working capital:

 

(Increase)/decrease in inventories

(272)

 (36)

(234)

(Increase)/decrease in trade and other receivables

(279)

(33)

272

Increase/(decrease) in trade and other payables

57

124

195

 

Cash generated from operations

(208) 

593

1,798

 

 

Taxation paid

-

-

-

 

Net cash from operating activities

(208)

593

1,798

 

 

 

Cash flow from investing activities

 

Payments to acquire property, plant and equipment

(390)

(93)

(444)

Proceeds from the sale of property, plant and equipment

1

-

11

Payments to acquire intangible assets

(110)

(29)

(306)

Net finance income/(costs)

-

10

12

 

Net cash outflow from investing activities

(499)

(112)

(727)

 

 

 

 

Cash flow from financing activities

 

Payment for right of use assets

(31)

(30)

(46)

Proceeds from new loans (note 6)

-

950

950

Loans repaid

-

-

(950)

Dividends paid

(193)

(174)

(314)

 

Net cash outflow from financing activities

(224)

746

(360)

 

 

 

 

 

Net increase in cash and cash equivalents

(931)

1,227

711

 

Effect of exchange rate differences on cash or cash equivalents

-

-

17

Cash and cash equivalents at beginning of period

4,410

3,682

3,682

Cash and cash equivalents at end of period

3,479

4,909

4,410

 

 

 

 

 

NOTES TO THE INTERIM FINANCIAL REPORT

 

 

1. BASIS OF PREPARATION OF INTERIM REPORT

As permitted, IAS34 'Interim Financial Reporting' has not been applied in this interim report. The information for the period ended 30 September 2022 is not audited and does not constitute statutory accounts as defined in section 434 of the Companies Act 2006. The statutory accounts for the year ended 31 March 2022 were given an unqualified audit report and did not contain statements under section 498(2) or 498(3) of the Companies Act 2006. A copy of the statutory accounts for that year has been delivered to the Registrar of Companies. The interim accounts for the half year ended 30 September 2021 were also unaudited.

2. ACCOUNTING POLICIES

Basis of accounting

The report has been prepared on a going concern basis in accordance UK-adopted International Accounting Standards.

 

The group has not availed itself of early adoption options in standards and interpretations.

 

The principal accounting policies adopted are as set out in the Annual Report for the year ended 31 March 2022. The valuation of inventories is considered to be the main area in terms of significant accounting estimates and judgements.

The retirement benefit scheme liability recognised in these interim accounts reflects the estimated change in the deficit at 30 September 2022 from the movements in discount rates and inflation during the six months.

3. DIVIDENDS

 

A final dividend for the financial year 2022 of 7.5625p per share (2021: 6.875p) was paid during the period.

 

An Interim dividend for the financial year 2023 of 5.5p per share is proposed (2022: 5.5p), payable on 25 March 2023.

4. EARNINGS/(LOSS) PER SHARE

The basic and diluted earnings per share are calculated by dividing the relevant profit after taxation of £488,000 (2021: profit £651,000) by the average number of ordinary shares in issue during the period being 2,534,322 (2021: 2,534,322). The number of shares used in the calculation is the same for both basic and diluted earnings.

5. OTHER OPERATING INCOME - GRANT FUNDING

Income has been received from government grants providing support during the Coronavirus pandemic:

Half year ended 30 September

Half year ended 30 September

Year ended 31 March

2022

2021

2022

Unaudited

Unaudited

Audited

£'000

£'000

£'000

 

 

 

 

 

Job Retention Scheme

-

 15

15

 

Total other operating income

-

15

15

 

 

Income has been accounted for under the accruals method.

 

 

 

 

 

NOTES TO THE INTERIM FINANCIAL REPORT

 

 

6. BORROWINGS

 

At the end of April 2021, the Company drew down a loan under the Coronavirus Business Interruption Loan Scheme (CBILS), for the value of £950,000, which under the standard terms is interest free for 12 months, with no penalty for early repayment.

This loan was repaid in full in March 2022.

7. RETIREMENT BENEFIT SCHEME

 

The retirement benefit scheme is valued in part using yield rates, as indicated by government bonds. Towards the end of September 2022, the rate of these bonds increased significantly, causing the valuation of the scheme to move from a liability to become an asset.

 

However, based on a review of the scheme deeds it is not clear whether the Company has an unconditional right to a refund and therefore for the purposes of the interim financial statements the surplus has not been recognised as an asset in accordance with the requirements of IAS 19 and IFRIC 14. In addition, the Directors believe that the gilt yields at 30 September 2022 are not likely to persist and indeed they have subsequently reduced. A future movement (reduction) in bond yields may return the scheme to a deficit position.

 

At 30 September 2022 the scheme had no exposure to Liability Driven Investments.

 

 

 

Note: 

Certain statements made in this announcement are forward-looking statements. These forward-looking statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections about its industry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify forward-looking statements. These statements are not a guarantee of future performance and are subject to known and unknown risks, uncertainties, and other factors, some of which are beyond the Company's control, are difficult to predict, and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. The Company cautions security holders and prospective security holders not to place undue reliance on these forward-looking statements, which reflect the view of the Company only as of the date of this announcement. The forward-looking statements made in this announcement relate only to events as of the date on which the statements are made. The Company will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances, or unanticipated events occurring after the date of this announcement except as required by law or by any appropriate regulatory authority. 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR BLBDBSUBDGDR
Date   Source Headline
21st Nov 20237:00 amRNSHalf-year Report
7th Sep 20231:53 pmRNSResult of AGM
21st Jul 20237:00 amRNSFinal Results
9th Dec 20221:48 pmRNSHolding(s) in Company
9th Dec 20221:45 pmRNSDirector/PDMR Shareholding
18th Nov 20227:00 amRNSHalf-year Report
25th Aug 20223:08 pmRNSResult of AGM
20th Jul 202212:40 pmRNSReplacement: Final Results
20th Jul 20227:00 amRNSFinal Results
12th Nov 20217:00 amRNSHalf-year Report
6th Aug 20211:35 pmRNSResult of AGM
19th Jul 202110:14 amRNSDirectorate Change
8th Jul 20212:34 pmRNSFinal Results
30th Dec 20207:00 amRNSDirectorate Change
12th Nov 20207:00 amRNSHalf-year Report
7th Aug 20202:35 pmRNSResult of AGM
10th Jul 20207:30 amRNSFinal Results
9th Jul 20204:13 pmRNSHolding(s) in Company
8th Apr 20203:40 pmRNSCOVID-19 Trading Update
6th Feb 20207:00 amRNSDirectorate Change
18th Dec 20197:00 amRNSDirector/PDMR Shareholding
10th Dec 20199:53 amRNSDirectorate Change
15th Nov 20197:00 amRNSHalf-year Report
9th Aug 20192:45 pmRNSResult of AGM
15th Jul 20194:38 pmRNSHolding(s) in Company
11th Jul 20197:00 amRNSFinal Results
1st Apr 201911:47 amRNSPDMR/PCA Dealing
8th Nov 20187:00 amRNSHalf-year Report
10th Aug 20181:01 pmRNSResult of AGM
12th Jul 20183:26 pmRNSFinal Results
15th Jan 201811:13 amRNSDividend Record Date
9th Nov 20177:00 amRNSHalf-year Report
13th Oct 20179:45 amRNSHolding(s) in Company
13th Oct 20179:43 amRNSHolding(s) in Company
29th Sep 20177:00 amRNSDirectorate Change
1st Sep 20179:22 amRNSDirectorate Change
14th Aug 201711:48 amRNSResult of AGM
12th Jul 20179:33 amRNSFinal Results
16th Jun 20177:00 amRNSDirector/PDMR Shareholding - Replacement
10th May 20172:34 pmRNSDirector/PDMR Shareholding
7th Mar 20173:36 pmRNSDirector/PDMR Dealing
28th Feb 20177:00 amRNSDirectorate Change
16th Nov 20168:00 amRNSHalf-year Report
29th Sep 20163:59 pmRNSDirectorate Change
12th Aug 20161:26 pmRNSResult of AGM
11th Aug 201612:22 pmRNSDirectorate Change
13th Jul 20167:00 amRNSFinal Results
7th Jul 20162:32 pmRNSNotice of Results
6th May 20167:00 amRNSChange of Adviser
4th Nov 20157:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.